
view our CenterWatch profile

(click on poster for more details)
We work with leading pharmaceutical companies and CROs including:
AstraZeneca to divest Nordic over-the-counter portfolio
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5419
AstraZeneca to Realign Supply Chain to Improve Productivity and Move Closer to Customers
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5417
AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5418
AstraZeneca Enters Agreement for Authorized Generic Pulmicort Respules
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5416
Phase III Studies Show That Vandetanib (ZACTIMA) Brings Clinical Benefits to Patients With Lung Cancer
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5414
FDA Responds to AstraZeneca’s Citizen Petition -- FDA Also Grants Approval for a Generic Version of Pulmicort Respules
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5415
SEROQUEL XR and SEROQUEL Approved in Europe for New Indications for the Treatment of Bipolar Disorder
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5413
CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5412
John Patterson to Retire from AstraZeneca
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5411
AstraZeneca PLC Third Quarter and Nine Months Results 2008
http://www.astrazeneca.com/r.aspx?s=rssfeed&p=Pressrelease_5410